Clinical Trial: ECOG-ACRIN EA3132

ECOG-ACRIN EA3132

Status: Open

Phase II Randomized Trial of Radiotherapy with or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing